Compare TASK & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TASK | PLSE |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 969.3M | 1.5B |
| IPO Year | 2021 | 2015 |
| Metric | TASK | PLSE |
|---|---|---|
| Price | $6.55 | $21.63 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $14.90 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 759.3K | 216.2K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | N/A |
| EPS | ★ 1.10 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.95 | $840.00 |
| Revenue Next Year | $6.46 | $287.54 |
| P/E Ratio | $5.95 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.53 | $12.56 |
| 52 Week High | $18.39 | $26.30 |
| Indicator | TASK | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 23.94 | 55.16 |
| Support Level | N/A | $13.75 |
| Resistance Level | $11.51 | $23.18 |
| Average True Range (ATR) | 0.48 | 1.40 |
| MACD | -0.25 | -0.02 |
| Stochastic Oscillator | 0.44 | 68.49 |
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world-wide Game-changing companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.